Answers are grounded in this paper and cite their sources.
Bioelectronic treatments targeting near-organ innervation have unprecedented clinical applications. Particularly in the spleen, the inhibition of the cholinergic inflammatory response by near-organ nerve stimulation has potential to replace pharmacological treatments in chronic and autoimmune diseases. A caveat is that the optimization of therapeutic stimulation parameters relies on
No takes yet. Share an insight, caveat, or question.
Lloyd et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: